Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections
Int Urol Nephrol. 2023 May;55(5):1159.
doi: 10.1007/s11255-023-03469-5.